Goldenwell Biotech (GWLL) Asset Writedowns and Impairment (2021 - 2023)

Goldenwell Biotech (GWLL) reported Asset Writedowns and Impairment of $711.0 for Q1 2023, up 278.19% on a YoY basis from $188.0 in Q1 2022, and up 278.19% quarter-over-quarter from $188.0 in Q1 2022.

Goldenwell Biotech (GWLL) Asset Writedowns and Impairment (2021 - 2023) Analysis & Trends

Goldenwell Biotech has reported Asset Writedowns and Impairment for 3 years, with the latest figure at $711.0 in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Paranovus Entertainment Technology 75,216.52 Bn 75,216.52 Bn -
2 Kraft Heinz 26.76 Bn 22.68 Bn 2.22 Bn
3 General Mills 17.79 Bn 17.02 Bn 1.37 Bn
4 Jbs 13.93 Bn 9.37 Bn 2.32 Bn
5 Hormel Foods 13.00 Bn 12.16 Bn 518.51 Mn
6 Mccormick 12.70 Bn 13.10 Bn 708.90 Mn
7 Magnum Ice Cream 12.17 Bn 11.70 Bn -
8 J M Smucker 11.05 Bn 10.99 Bn 827.80 Mn
9 Smithfield Foods 10.57 Bn 9.49 Bn 511.00 Mn
10 Goldenwell Biotech - - 25,000.00

Historic Data

Download Data
DateValue
Mar 31, 2023 711.00
Mar 31, 2023 711.00
Mar 31, 2022 188.00
Mar 31, 2022 188.00
Sep 30, 2021 5,573.00
Sep 30, 2021 5,573.00
Jun 30, 2021 5,545.00
Jun 30, 2021 5,545.00
Mar 31, 2021 -63,561.00
Mar 31, 2021 -63,561.00